4//SEC Filing
Sage Therapeutics, Inc. 4
Accession 0001562180-16-003826
CIK 0001597553operating
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:18 PM ET
Size
7.8 KB
Accession
0001562180-16-003826
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-12-08+14,400→ 68,000 totalExercise: $38.25From: 2016-12-08Exp: 2025-01-23→ Common Stock (14,400 underlying)
Footnotes (1)
- [F1]The securities awarded on 1/23/2015 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 5,000 shares of common stock vested on the one year anniversary of the Vesting Start Date with 15,000 shares vesting in 36 equal monthly installments thereafter. Options to purchase 48,000 shares of common stock vest periodically over four years from the grant date upon the company reaching certain milestone requirements, of which the performance criteria were met with the respect of 14,400 shares.
Documents
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001597553
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:18 PM ET
- Size
- 7.8 KB